{"transactions":[{"id":4628572,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-02T23:47:01.000Z","date":"2026-09-30","kind":"sale","planned":false,"acquired":false,"shares":556000,"price":4.9568,"value":2755980.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":3236171,"source":{"system":"sec-edgar","filing":"0002042266-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226626000002/primary_doc.xml","form_type":"4"}},{"id":4615836,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2026-09-11T20:09:50.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":false,"shares":392157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-25","underlying":"Common Stock","underlying_shares":392157},"source":{"system":"sec-edgar","filing":"0001140361-26-036347","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000114036126036347/form4.xml","form_type":"4"}},{"id":4615835,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-11T20:09:50.000Z","date":"2026-09-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":75541,"price":5.97,"value":450979.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person paid the exercise price of the Warrant on a cashless basis.  The Issuer withheld 75,541 shares, calculated in accordance with the terms of the Warrant, to pay the exercise price and issued the remaining 316,616 shares to the Reporting Person."}],"balance_after":2048485,"source":{"system":"sec-edgar","filing":"0001140361-26-036347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000114036126036347/form4.xml","form_type":"4"}},{"id":4615834,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-11T20:09:50.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":true,"shares":392157,"price":1.15,"value":450980.55,"ownership":{"direct":true},"balance_after":2124026,"source":{"system":"sec-edgar","filing":"0001140361-26-036347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000114036126036347/form4.xml","form_type":"4"}},{"id":3513291,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Warrant (right to buy)","published_at":"2026-09-08T20:05:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":784314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-25","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001140361-26-035913","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557832/000114036126035913/form4.xml","form_type":"4"}},{"id":3513290,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-08T20:05:55.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":784314,"price":1.15,"value":901961.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In conjunction with the exercise of the Warrant reported herein, the Reporting Person entered into a Lock-Up Agreement with the Issuer dated September 6, 2026 (the \"Lock-Up Agreement\").  Pursuant to the Lock-Up Agreement, among other terms, the Reporting Person agreed that, without the prior written consent of the Issuer, during the period beginning on September 6, 2026 and ending at the close of business 180 days after the issuance of the shares of Common Stock underlying the Warrant, the Reporting Person will not transfer or dispose of, directly or indirectly, any shares of Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the Reporting Person and securities which may be issued upon exercise of a stock option or warrant), as further described in the Lock-Up Agreement and subject to certain exclusions described therein."}],"balance_after":2800111,"source":{"system":"sec-edgar","filing":"0001140361-26-035913","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557832/000114036126035913/form4.xml","form_type":"4"}},{"id":3513292,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:05:48.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":28000,"price":4.5433,"value":127212.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"A portion of the shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer, to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 30, 2026.   The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $4.29 to $4.79, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":556375,"source":{"system":"sec-edgar","filing":"0001140361-26-035912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1504983/000114036126035912/form4.xml","form_type":"4"}},{"id":703093,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-07-27T20:08:29.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":7429,"price":2.97,"value":22064.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award.  This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":704106,"source":{"system":"sec-edgar","filing":"0000905148-26-003354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826003354/form4.xml","form_type":"4"}},{"id":703095,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:07:54.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":4644,"price":2.94,"value":13653.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award.  This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":291440,"source":{"system":"sec-edgar","filing":"0000905148-26-003353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514826003353/form4.xml","form_type":"4"}},{"id":703043,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:07:20.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":9475,"price":2.9473,"value":27925.6675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award.  This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9009 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1731869,"source":{"system":"sec-edgar","filing":"0000905148-26-003352","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514826003352/form4.xml","form_type":"4"}},{"id":702900,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:06:50.000Z","date":"2026-07-23","kind":"sale","planned":false,"acquired":false,"shares":7783,"price":2.9477,"value":22941.9491,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award.  This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9006 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":584375,"source":{"system":"sec-edgar","filing":"0000905148-26-003351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826003351/form4.xml","form_type":"4"}},{"id":770292,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-20T23:29:44.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":1700000,"price":4.35,"value":7395000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":3792171,"source":{"system":"sec-edgar","filing":"0002042266-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226626000001/primary_doc.xml","form_type":"4"}},{"id":800297,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-04-27T20:28:53.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":7470,"price":5.2371,"value":39121.137,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2314 to $5.2413, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":711535,"source":{"system":"sec-edgar","filing":"0000905148-26-001867","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826001867/form4.xml","form_type":"4"}},{"id":800300,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-27T20:28:24.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":4697,"price":5.2202,"value":24519.2794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":296084,"source":{"system":"sec-edgar","filing":"0000905148-26-001866","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514826001866/form4.xml","form_type":"4"}},{"id":799997,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-04-27T20:27:53.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":1641,"price":5.204,"value":8539.764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":188671,"source":{"system":"sec-edgar","filing":"0000905148-26-001865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001865/form4.xml","form_type":"4"}},{"id":800149,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-27T20:27:16.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":9511,"price":5.22,"value":49647.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":1741344,"source":{"system":"sec-edgar","filing":"0000905148-26-001864","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514826001864/form4.xml","form_type":"4"}},{"id":800154,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2026-04-27T20:26:45.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":7542,"price":5.1917,"value":39155.8014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.18 to $5.21, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":509233,"source":{"system":"sec-edgar","filing":"0000905148-26-001863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514826001863/form4.xml","form_type":"4"}},{"id":799988,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-27T20:26:01.000Z","date":"2026-04-23","kind":"sale","planned":false,"acquired":false,"shares":7842,"price":5.1846,"value":40657.6332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.1828 to $5.1901, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":592158,"source":{"system":"sec-edgar","filing":"0000905148-26-001862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001862/form4.xml","form_type":"4"}},{"id":802608,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:32:27.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":343022,"source":{"system":"sec-edgar","filing":"0000905148-26-001788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001788/form4.xml","form_type":"4"}},{"id":802607,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:31:08.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":127514,"source":{"system":"sec-edgar","filing":"0000905148-26-001786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001786/form4.xml","form_type":"4"}},{"id":802609,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:30:42.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":2015797,"source":{"system":"sec-edgar","filing":"0000905148-26-001785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001785/form4.xml","form_type":"4"}},{"id":802605,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51608,"kind":"person","name":"Benton Susan","position":1,"cik":"0001373649","reported_name":"Benton Susan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:30:19.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":243894,"source":{"system":"sec-edgar","filing":"0000905148-26-001784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001784/form4.xml","form_type":"4"}},{"id":803356,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:28:06.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":259019,"source":{"system":"sec-edgar","filing":"0000905148-26-001782","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000090514826001782/form4.xml","form_type":"4"}},{"id":802606,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:26:41.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":321692,"source":{"system":"sec-edgar","filing":"0000905148-26-001781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001781/form4.xml","form_type":"4"}},{"id":802610,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51611,"kind":"person","name":"MANUSO JAMES S J","position":1,"cik":"0001236365","reported_name":"MANUSO JAMES S J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T16:31:58.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":317318,"source":{"system":"sec-edgar","filing":"0000905148-26-001787","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236365/000090514826001787/form4.xml","form_type":"4"}},{"id":835497,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:12:35.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3719,"price":5.2501,"value":19525.1219,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":300781,"source":{"system":"sec-edgar","filing":"0000905148-26-001384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514826001384/form4.xml","form_type":"4"}},{"id":834758,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-03-18T20:11:39.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":2816,"price":5.245,"value":14769.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."}],"balance_after":190312,"source":{"system":"sec-edgar","filing":"0000905148-26-001382","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001382/form4.xml","form_type":"4"}},{"id":835306,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:10:31.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":24438,"price":5.2102,"value":127326.8676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.21 to $5.215, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1750855,"source":{"system":"sec-edgar","filing":"0000905148-26-001381","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514826001381/form4.xml","form_type":"4"}},{"id":835323,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2026-03-18T20:09:24.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3719,"price":5.1213,"value":19046.1147,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":516775,"source":{"system":"sec-edgar","filing":"0000905148-26-001380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514826001380/form4.xml","form_type":"4"}},{"id":901381,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2026-02-17T22:14:08.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":5313,"price":3.39,"value":18011.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":520494,"source":{"system":"sec-edgar","filing":"0000905148-26-000904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514826000904/form4.xml","form_type":"4"}},{"id":931349,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-01-27T00:51:09.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":719005,"source":{"system":"sec-edgar","filing":"0000905148-26-000359","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514826000359/form4.xml","form_type":"4"}},{"id":931350,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-27T00:50:02.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":304500,"source":{"system":"sec-edgar","filing":"0000905148-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514826000358/form4.xml","form_type":"4"}},{"id":931085,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-27T00:49:14.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":86500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":193128,"source":{"system":"sec-edgar","filing":"0000905148-26-000357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000357/form4.xml","form_type":"4"}},{"id":931271,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-27T00:48:07.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":483639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":1775293,"source":{"system":"sec-edgar","filing":"0000905148-26-000356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514826000356/form4.xml","form_type":"4"}},{"id":931272,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"officer":true,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2026-01-27T00:46:45.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":525807,"source":{"system":"sec-edgar","filing":"0000905148-26-000355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514826000355/form4.xml","form_type":"4"}},{"id":931084,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-27T00:45:07.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0000905148-26-000354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000354/form4.xml","form_type":"4"}},{"id":934095,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-21T21:05:27.000Z","date":"2026-01-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3390,"price":2.1,"value":7119.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":106628,"source":{"system":"sec-edgar","filing":"0000905148-26-000282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000282/form4.xml","form_type":"4"}},{"id":939949,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"Head of Fin. Quality Assurance"}}],"security":"Common Stock","published_at":"2026-01-13T22:21:47.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3950,"price":1.93,"value":7623.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":110018,"source":{"system":"sec-edgar","filing":"0000905148-26-000164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000164/form4.xml","form_type":"4"}},{"id":943112,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-08T21:13:05.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":1991430,"source":{"system":"sec-edgar","filing":"0000905148-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000088/form4.xml","form_type":"4"}},{"id":950607,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:22:44.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":23643,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":103147,"source":{"system":"sec-edgar","filing":"0000905148-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000031/form4.xml","form_type":"4"}},{"id":953876,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:21:55.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":21127,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":234652,"source":{"system":"sec-edgar","filing":"0000905148-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000090514826000028/form4.xml","form_type":"4"}},{"id":950606,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:21:13.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":42507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":297325,"source":{"system":"sec-edgar","filing":"0000905148-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000027/form4.xml","form_type":"4"}},{"id":950648,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51611,"kind":"person","name":"MANUSO JAMES S J","position":1,"cik":"0001236365","reported_name":"MANUSO JAMES S J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T16:23:54.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":31188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":292951,"source":{"system":"sec-edgar","filing":"0000905148-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236365/000090514826000036/form4.xml","form_type":"4"}},{"id":956412,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a grant of restricted stock units (\"RSUs\") which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."},{"field":"shares","element":"transactionShares","label":"F5","text":"On December 31, 2025, the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 6, 2026, of an additional 67,000 RSUs which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":1924430,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":956411,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":83000,"price":1.9689,"value":163418.7,"ownership":{"direct":false,"nature":"By Garret Gallagher - Custodian UTMA/UGMA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9476 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":956410,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-31T21:33:33.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":81000,"price":1.9787,"value":160274.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.945 to $1.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1891430,"source":{"system":"sec-edgar","filing":"0000905148-25-004511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825004511/form4.xml","form_type":"4"}},{"id":972855,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-11T22:35:47.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":4000000,"price":2.15,"value":8600000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":5492171,"source":{"system":"sec-edgar","filing":"0002042266-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000204226625000003/primary_doc.xml","form_type":"4"}},{"id":1006939,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-05T21:06:41.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":30350,"price":2.3,"value":69805.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities."}],"balance_after":1291654,"source":{"system":"sec-edgar","filing":"0000905148-25-003777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825003777/form4.xml","form_type":"4/A","original_submission_date":"2025-11-04"}},{"id":1008383,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-04T21:22:03.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":30350,"price":2.3,"value":69805.0,"ownership":{"direct":true},"balance_after":1291654,"source":{"system":"sec-edgar","filing":"0000905148-25-003767","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825003767/form4.xml","form_type":"4"}},{"id":1013938,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-10-24T20:16:14.000Z","date":"2025-10-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":23795,"price":1.95,"value":46400.25,"ownership":{"direct":true},"balance_after":319005,"source":{"system":"sec-edgar","filing":"0000905148-25-003670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514825003670/form4.xml","form_type":"4"}},{"id":1042611,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-11T22:03:52.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service."}],"balance_after":250000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-09-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000905148-25-003320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003320/form4.xml","form_type":"4"}},{"id":1042610,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28521,"kind":"person","name":"Gagnon Robert E.","position":1,"cik":"0001504983","reported_name":"Gagnon Robert E.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-11T22:03:52.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000905148-25-003320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003320/form4.xml","form_type":"4"}},{"id":1054415,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-27T20:15:19.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":869565,"price":1.15,"value":999999.75,"ownership":{"direct":true},"balance_after":1810430,"source":{"system":"sec-edgar","filing":"0000905148-25-003152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003152/form4.xml","form_type":"4"}},{"id":1054414,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-27T20:13:53.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":86956,"price":1.15,"value":99999.4,"ownership":{"direct":true},"balance_after":254818,"source":{"system":"sec-edgar","filing":"0000905148-25-003151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003151/form4.xml","form_type":"4"}},{"id":1157611,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2025-05-06T22:05:27.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":6927.419,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":0,"derivative":{"exercise_date":"2025-05-05","underlying":"Common Stock","underlying_shares":6927419},"source":{"system":"sec-edgar","filing":"0001578563-25-000238","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000157856325000238/primary_doc.xml","form_type":"4"}},{"id":1157610,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":45730,"kind":"person","name":"Foundation Fighting Blindness Retinal Degeneration Fund","position":1,"cik":"0002042266","reported_name":"Foundation Fighting Blindness Retinal Degeneration Fund","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":45731,"kind":"person","name":"Foundation Fighting Blindness, Inc.","position":2,"cik":"0002042532","reported_name":"Foundation Fighting Blindness, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-06T22:05:27.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":6927419,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A non-voting convertible preferred stock (the \"Preferred Stock\") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Foundation Fighting Blindness, Inc. (\"FFB\") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (\"RDF\") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold."}],"balance_after":9492171,"source":{"system":"sec-edgar","filing":"0001578563-25-000238","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042532/000157856325000238/primary_doc.xml","form_type":"4"}},{"id":1160923,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:09:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001430","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001430/form4.xml","form_type":"4"}},{"id":1160922,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:09:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":318655,"source":{"system":"sec-edgar","filing":"0000905148-25-001430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001430/form4.xml","form_type":"4"}},{"id":1160925,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:06:36.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001428","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001428/form4.xml","form_type":"4"}},{"id":1160924,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:06:36.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79504,"source":{"system":"sec-edgar","filing":"0000905148-25-001428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001428/form4.xml","form_type":"4"}},{"id":1160921,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:05:38.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001427","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001427/form4.xml","form_type":"4"}},{"id":1160920,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:05:38.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":940865,"source":{"system":"sec-edgar","filing":"0000905148-25-001427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001427/form4.xml","form_type":"4"}},{"id":1160917,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51608,"kind":"person","name":"Benton Susan","position":1,"cik":"0001373649","reported_name":"Benton Susan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:04:03.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001426/form4.xml","form_type":"4"}},{"id":1160916,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51608,"kind":"person","name":"Benton Susan","position":1,"cik":"0001373649","reported_name":"Benton Susan","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:04:03.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":219527,"source":{"system":"sec-edgar","filing":"0000905148-25-001426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001426/form4.xml","form_type":"4"}},{"id":1161795,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:03:05.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001425","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000090514825001425/form4.xml","form_type":"4"}},{"id":1161794,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:03:05.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":213525,"source":{"system":"sec-edgar","filing":"0000905148-25-001425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000090514825001425/form4.xml","form_type":"4"}},{"id":1160919,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:02:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001424/form4.xml","form_type":"4"}},{"id":1160918,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:02:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":167862,"source":{"system":"sec-edgar","filing":"0000905148-25-001424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001424/form4.xml","form_type":"4"}},{"id":1160932,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51611,"kind":"person","name":"MANUSO JAMES S J","position":1,"cik":"0001236365","reported_name":"MANUSO JAMES S J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T17:08:08.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001429","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236365/000090514825001429/form4.xml","form_type":"4"}},{"id":1160931,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51611,"kind":"person","name":"MANUSO JAMES S J","position":1,"cik":"0001236365","reported_name":"MANUSO JAMES S J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T17:08:08.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":261763,"source":{"system":"sec-edgar","filing":"0000905148-25-001429","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236365/000090514825001429/form4.xml","form_type":"4"}},{"id":1191089,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2025-03-26T20:10:20.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":392157,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":392157,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":392157},"source":{"system":"sec-edgar","filing":"0000905148-25-001007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825001007/form4.xml","form_type":"4"}},{"id":1191088,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-26T20:10:20.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":392157,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."}],"balance_after":1322004,"source":{"system":"sec-edgar","filing":"0000905148-25-001007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825001007/form4.xml","form_type":"4"}},{"id":1190740,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Warrants (right to buy)","published_at":"2025-03-26T20:08:12.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day."}],"balance_after":784314,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-24","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0000905148-25-001006","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001006/form4.xml","form_type":"4"}},{"id":1190739,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51610,"kind":"person","name":"Gallagher Cam","position":1,"cik":"0001557832","reported_name":"Gallagher Cam","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-26T20:08:12.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275."}],"balance_after":861361,"source":{"system":"sec-edgar","filing":"0000905148-25-001006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001006/form4.xml","form_type":"4"}},{"id":1204313,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:56:45.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":52500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000905148-25-000942","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514825000942/form4.xml","form_type":"4"}},{"id":1204312,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28604,"kind":"person","name":"SCHACHLE JOSEPH K","position":1,"cik":"0001145914","reported_name":"SCHACHLE JOSEPH K","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-18T00:56:45.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":54500,"source":{"system":"sec-edgar","filing":"0000905148-25-000942","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145914/000090514825000942/form4.xml","form_type":"4"}},{"id":1203535,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:54:51.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":39500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0000905148-25-000941","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000941/form4.xml","form_type":"4"}},{"id":1203534,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2025-03-18T00:54:51.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":113968,"source":{"system":"sec-edgar","filing":"0000905148-25-000941","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000941/form4.xml","form_type":"4"}},{"id":1204201,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:53:56.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":330697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":330697,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":330697},"source":{"system":"sec-edgar","filing":"0000905148-25-000940","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825000940/form4.xml","form_type":"4"}},{"id":1204200,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-18T00:53:56.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":330697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":929847,"source":{"system":"sec-edgar","filing":"0000905148-25-000940","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514825000940/form4.xml","form_type":"4"}},{"id":1204220,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":19972,"kind":"person","name":"Jhaveri Nirav S.","position":1,"cik":"0002011481","reported_name":"Jhaveri Nirav S.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:52:04.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":52500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000905148-25-000939","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2011481/000090514825000939/form4.xml","form_type":"4"}},{"id":1204219,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":19972,"kind":"person","name":"Jhaveri Nirav S.","position":1,"cik":"0002011481","reported_name":"Jhaveri Nirav S.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T00:52:04.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":194293,"source":{"system":"sec-edgar","filing":"0000905148-25-000939","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011481/000090514825000939/form4.xml","form_type":"4"}},{"id":1204214,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"officer":true,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:50:58.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":52500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000905148-25-000938","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514825000938/form4.xml","form_type":"4"}},{"id":1204213,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"officer":true,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2025-03-18T00:50:58.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":125807,"source":{"system":"sec-edgar","filing":"0000905148-25-000938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514825000938/form4.xml","form_type":"4"}},{"id":1203537,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":81896,"kind":"person","name":"Hoffmann Bernhard","position":1,"cik":"0001830354","reported_name":"Hoffmann Bernhard","relationship":{"officer":true,"officer_title":"SVP of Corp. Dev."}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-18T00:49:52.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":29500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service."}],"balance_after":29500,"derivative":{"exercise_price":0.93,"expiration_date":"2035-03-12","underlying":"Common Stock","underlying_shares":29500},"source":{"system":"sec-edgar","filing":"0000905148-25-000937","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000937/form4.xml","form_type":"4"}},{"id":1203536,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":81896,"kind":"person","name":"Hoffmann Bernhard","position":1,"cik":"0001830354","reported_name":"Hoffmann Bernhard","relationship":{"officer":true,"officer_title":"SVP of Corp. Dev."}}],"security":"Common Stock","published_at":"2025-03-18T00:49:52.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":29500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service."}],"balance_after":185446,"source":{"system":"sec-edgar","filing":"0000905148-25-000937","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000937/form4.xml","form_type":"4"}},{"id":1264310,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":19972,"kind":"person","name":"Jhaveri Nirav S.","position":1,"cik":"0002011481","reported_name":"Jhaveri Nirav S.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:05:15.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":8207,"price":1.15,"value":9438.05,"ownership":{"direct":true},"balance_after":141793,"source":{"system":"sec-edgar","filing":"0000905148-25-000713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011481/000090514825000713/form4.xml","form_type":"4"}},{"id":1264309,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51189,"kind":"person","name":"Jayagopal Ashwath","position":1,"cik":"0002008983","reported_name":"Jayagopal Ashwath","relationship":{"officer":true,"officer_title":"Chief Scientific & Dev. Ofc."}}],"security":"Common Stock","published_at":"2025-02-18T21:04:51.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5193,"price":1.15,"value":5971.95,"ownership":{"direct":true},"balance_after":73307,"source":{"system":"sec-edgar","filing":"0000905148-25-000712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008983/000090514825000712/form4.xml","form_type":"4"}},{"id":1280167,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51160,"kind":"person","name":"Zaremba Rabourn Amy","position":1,"cik":"0001832343","reported_name":"Zaremba Rabourn Amy","relationship":{"officer":true,"officer_title":"SVP of Finance"}}],"security":"Common Stock","published_at":"2025-02-06T21:37:16.000Z","date":"2025-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":8190,"price":1.14,"value":9336.6,"ownership":{"direct":true},"balance_after":74468,"source":{"system":"sec-edgar","filing":"0000905148-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000403/form4.xml","form_type":"4"}},{"id":1280165,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":81896,"kind":"person","name":"Hoffmann Bernhard","position":1,"cik":"0001830354","reported_name":"Hoffmann Bernhard","relationship":{"officer":true,"officer_title":"SVP of Corp. Dev."}}],"security":"Common Stock","published_at":"2025-02-06T21:35:31.000Z","date":"2025-02-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":6751,"price":1.14,"value":7696.14,"ownership":{"direct":true},"balance_after":155946,"source":{"system":"sec-edgar","filing":"0000905148-25-000401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825000401/form4.xml","form_type":"4"}},{"id":1312124,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":42599,"kind":"person","name":"Bennett Jean","position":1,"cik":"0001872219","reported_name":"Bennett Jean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T21:42:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant."}],"balance_after":134021,"source":{"system":"sec-edgar","filing":"0000905148-25-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872219/000090514825000038/form4.xml","form_type":"4"}},{"id":1310121,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51611,"kind":"person","name":"MANUSO JAMES S J","position":1,"cik":"0001236365","reported_name":"MANUSO JAMES S J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T16:43:25.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":50222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant."}],"balance_after":182259,"source":{"system":"sec-edgar","filing":"0000905148-25-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236365/000090514825000039/form4.xml","form_type":"4"}},{"id":1320499,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-30T21:26:20.000Z","date":"2024-12-26","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.976,"value":97600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.97 to $0.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":599150,"source":{"system":"sec-edgar","filing":"0000905148-24-003425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514824003425/form4.xml","form_type":"4"}},{"id":1323076,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-23T22:50:32.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued to the Reporting Person to correct an inadvertent over-withholding of shares on November 1, 2024, in connection with the vesting of restricted stock units on that date."}],"balance_after":499150,"source":{"system":"sec-edgar","filing":"0000905148-24-003406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514824003406/form4.xml","form_type":"4"}},{"id":1353017,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-11-25T21:18:07.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9834,"value":9834.0,"ownership":{"direct":true},"balance_after":342800,"source":{"system":"sec-edgar","filing":"0000905148-24-003268","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514824003268/form4.xml","form_type":"4"}},{"id":1359730,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-19T21:08:37.000Z","date":"2024-11-18","kind":"purchase","planned":false,"acquired":true,"shares":9706,"price":1.0244,"value":9942.8264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.005 to $1.06, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":492950,"source":{"system":"sec-edgar","filing":"0000905148-24-003236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514824003236/form4.xml","form_type":"4"}},{"id":1359729,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-19T21:08:37.000Z","date":"2024-11-15","kind":"purchase","planned":false,"acquired":true,"shares":90294,"price":1.0102,"value":91214.9988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.975 to $1.05, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":483244,"source":{"system":"sec-edgar","filing":"0000905148-24-003236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514824003236/form4.xml","form_type":"4"}},{"id":1369389,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28603,"kind":"person","name":"YERXA BENJAMIN R","position":1,"cik":"0001145910","reported_name":"YERXA BENJAMIN R","relationship":{"director":true,"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2024-11-12T21:35:35.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":332800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest in four equal installments on the first, second, third, and fourth anniversary of October 22, 2024, subject to the Reporting Person's continuing service."}],"balance_after":332800,"source":{"system":"sec-edgar","filing":"0000905148-24-003015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145910/000090514824003015/form4.xml","form_type":"4"}},{"id":1375708,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":28572,"kind":"person","name":"Magrath George","position":1,"cik":"0001999390","reported_name":"Magrath George","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-05T21:13:40.000Z","date":"2024-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":37050,"price":1.18,"value":43719.0,"ownership":{"direct":true},"balance_after":392950,"source":{"system":"sec-edgar","filing":"0000905148-24-002934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999390/000090514824002934/form4.xml","form_type":"4"}},{"id":1381860,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36277,"kind":"person","name":"Graves Adrienne L","position":1,"cik":"0001326192","reported_name":"Graves Adrienne L","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-10-24T21:59:15.000Z","date":"2024-10-22","kind":"grant","planned":false,"acquired":true,"shares":172874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service."}],"balance_after":172874,"derivative":{"exercise_price":1.33,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":172874},"source":{"system":"sec-edgar","filing":"0000905148-24-002828","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824002828/form4.xml","form_type":"4"}}],"next_cursor":"2024-10-24T21:59:15.000000Z,1381860"}